Malaysia vs Syrian Arab Republic: Access to anti-retroviral drugs, male
Malaysia
59.0%
in 2024
Syrian Arab Republic
59.0%
in 2024
Malaysia rank
105th
Syrian Arab Republic rank
105th
Access to anti-retroviral drugs, male over time
- Malaysia
- Syrian Arab Republic
How they compare
Malaysia currently reports 59.0% against 59.0% in Syrian Arab Republic, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Syrian Arab Republic ahead.
Malaysia ranks 105th and Syrian Arab Republic ranks 105th of 141 countries.
Malaysia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malaysia | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.2% | 2.5% | 4.7% | Malaysia |
| 2010s | 29.7% | 21.2% | 8.5% | Malaysia |
| 2020s | 55.6% | 51.6% | 4.0% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Malaysia or Syrian Arab Republic?
- Malaysia, at 59.0% against 59.0% in Syrian Arab Republic as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Malaysia and Syrian Arab Republic?
- 0.0%, with Malaysia ahead.
- How many years of comparable data are there for Malaysia and Syrian Arab Republic?
- 25 years are reported by both, from 2000 to 2024.
- How do Malaysia and Syrian Arab Republic rank globally for access to anti-retroviral drugs, male?
- Malaysia ranks 105th and Syrian Arab Republic ranks 105th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.